Firmus Eyes Up to $5 Billion in Australian IPO Amid Growing Investor Interest
Firmus, a prominent player in the biotechnology sector, is reportedly planning to raise up to $5 billion through an initial public offering (IPO) in Australia. This move comes as the company seeks to capitalize on increasing investor interest and expand its operations.